New Neurosteroid Reduces Major Depressive Disorder Symptoms - MD Magazine

Submitted by Anonymous (not verified) on Thu, 09/05/2019 - 13:02

New Neurosteroid Reduces Major Depressive Disorder Symptoms  MD MagazineIn a double-blind, phase 2 trial, investigators find that SAGE-17 results in a reduction of depressive symptoms after 2 weeks.